Tom Santamaria

China Medicine: Expect a Big Quarter

Its about time someone to notice of CHME by posting this outstanding and clear picture of what maybe a breakout quarter on the way to more of the same in future quarters.

In my opinion CHME is not only a good nearterm play but a great longterm play as well. With ADTZ and its nearly 90% gross margins coming into play I really do see a great longterm stock to own.